Quantcast

Latest Neurogenesis Stories

2011-07-21 11:22:00

ROCKVILLE, Md., July 21, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received a patent covering the transplantation of human neural cells for the treatment of neurodegenerative conditions from the Russian Federation. The claims include methods of culturing the cells as well as treating amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), spinal cord injuries, traumatic brain injury, multiple sclerosis, cerebral palsy, epilepsy, Huntington's disease...

2011-07-14 07:02:00

ROCKVILLE, Md., July 14, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth." The patents cover three new compounds and include both structure and method claims for inducing neurogenesis and the growth of new neurons, both in-vitro and in-vivo. (Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO ) Neuralstem's first...

2011-07-13 23:28:44

Duke University Medical Center researchers have found that a "fountain of youth" that sustains the production of new neurons in the brains of rodents is also believed to be present in the human brain. The existence of a vital support system of cells around stem cells in the brain explains why stem cells by themselves can't generate neurons in a lab dish, a major roadblock in using these stem cells for injury repair. "We believe these findings will have important implications for human...

2011-07-13 13:47:25

Stem cell therapy may restore cognition in patients with brain cancer who experience functional learning and memory loss often associated with radiation treatment, according to a laboratory study published in Cancer Research, a journal of the American Association for Cancer Research. Charles Limoli, Ph.D., a professor in the department of radiation oncology at the University of California, Irvine, said radiation therapy is the standard of care for most brain cancers, but the side effects can...

2011-07-07 18:50:23

Separating the neural wheat from the chaff University of Florida scientists have discovered a way to separate the neural wheat from the chaff during the process of generating brain cells for potential patient therapies. The technique, recently detailed in the online journal PLoS ONE, could be applied to long-awaited stem cell treatments for Parkinson's disease, spinal cord injuries and other brain disorders. It would allow doctors to deliver neurons to patients, without including vast amounts...

2011-06-20 09:00:00

ROCKVILLE, Md., June 20, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has been approved to dose the final cohort in the ongoing Phase Ia trial to test the safety of NSI-189 for the treatment of major depression. Phase Ia is testing the drug in healthy volunteers for safety and tolerability. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be...

2011-06-13 15:37:21

    * Hippocampus adapts to environmental stresses    * Stockpiles neuronal stem cells under deprived conditions, produces more neurons under favorable conditions    * Knowledge of how neural stem cells produce neurons could lead to potential treatment for neurodegenerative diseases such as Alzheimer's and Parkinson's Scientists have known for years that neurogenesis takes place throughout adulthood in the hippocampus of the mammalian brain. Now...

2011-06-07 08:41:00

ROCKVILLE, Md., June 7, 2011 /PRNewswire/ -- Neuralstem, Inc. (NYSE Amex: CUR) announced that it has signed an exclusive agency licensing agreement with Summit Pharmaceuticals International Corporation, of Tokyo, Japan (SPI), a wholly owned subsidiary of Sumitomo Corporation Group. Under the agreement, SPI will market development and licensing rights to NSI-189, Neuralstem's neurogenic compound, currently in an FDA-approved Phase I clinical trial for major depression. (Logo:...

2011-05-12 00:00:46

Hippocampal stems cells for use in neuroscience and cytotoxicity testing. Branford, CT (PRWEB) May 11, 2011 GigaCyte, LLC., a leading provider of human stem cell-based products and preclinical contract research services, headquartered in Branford, Connecticut USA, announced the launch of human hippocampal stem cells for use in neuroscience and cytotoxicity testing. GigaCyte's hippocampal stem cells have been extensively characterized for neural stem cell and mature neural markers. This...

bcd51dad39d6fd8c1f71f2f60c2c8d651
2011-04-26 14:21:54

Abundant precursor cells can become many types of neurons without introducing tumor risk In a paper published in the April 25 early online edition of the Proceedings of the National Academy of Sciences, researchers at the University of California, San Diego School of Medicine, the Gladstone Institutes in San Francisco and colleagues report a game-changing advance in stem cell science: the creation of long-term, self-renewing, primitive neural precursor cells from human embryonic stem cells...


Word of the Day
sough
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'
Related